Motavizumab - New Biological Therapy for RSV Prevention

Print-Icon
Print

RSV is a negative-sense, enveloped RNA virus that infects the upper respiratory tract but in vulnerable patients may rapidly progress to viral pneumonia.
 
«Back | Next»

Return to Project




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development